Gamma interferon (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 18 | Spinocerebellar degeneration | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03888664 (ClinicalTrials.gov) | June 26, 2016 | 10/3/2019 | Open Trail of ?IFN for Friedreich Ataxia | Safety and Efficacy of ?IFN Treatment in Friedreich Ataxia | Friedreich Ataxia | Drug: gamma interferon | IRCCS Eugenio Medea | NULL | Completed | 10 Years | 40 Years | All | 12 | Phase 2 | NULL |
| 2 | NCT02035020 (ClinicalTrials.gov) | May 2013 | 12/1/2014 | A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients | A Phase IIa Clinical Trial to Test the Safety and Efficacy of Interferon Gamma Treatment in Elevating Frataxin Levels in Friedreich's Ataxia (FRDA) Patients | Friedreich Ataxia | Drug: gamma interferon | Azienda Policlinico Umberto I | NULL | Completed | 18 Years | 45 Years | All | 10 | Phase 2 | Italy |